CSat Investment Advisory’s Allergan plc AGN Stock Holding History

CSat Investment Advisory’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-768	Closed	-$136K	–	1193
2020 Q1	$136K	Buy	768 +87	+13%	+$16.4K	0.03%	295
2019 Q4	$130K	Buy	681 +103	+18%	+$18.6K	0.03%	312
2019 Q3	$98K	Buy	578 +18	+3%	+$2.93K	0.03%	320
2019 Q2	$94K	Buy	560 +518	+1,233%	+$71.7K	0.03%	307
2019 Q1	$6K	Buy	42 +6	+17%	+$870	﹤0.01%	492
2018 Q4	$5K	Buy	36 +19	+112%	+$3.12K	﹤0.01%	493
2018 Q3	$3K	Sell	17 -1	-6%	-$184	﹤0.01%	515
2018 Q2	$3K	Buy	+18	New	+$2.89K	﹤0.01%	514

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

CSat Investment Advisory's AGN Position: Q2 2020 in Review

CSat Investment Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 768 shares — an estimated $136K sold.

CSat Investment Advisory first reported a position in AGN in Q2 2018 and held it in 8 quarters. The position peaked at $136K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

CSat Investment Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
CSat Investment Advisory sold 768 Allergan plc shares in Q2 2020, an estimated $136K.
CSat Investment Advisory first reported a position in Allergan plc in Q2 2018 and held it in 8 quarters.
CSat Investment Advisory's Allergan plc position peaked at $136K in Q1 2020.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on CSat Investment Advisory's 13F filing for Q2 2020, filed 7 Aug 2020.